Pharma Pulse 1/29/25: USP Calls for Pharmacists to Volunteer, Regulatory Response to Abuse-Deterrent Drugs & more

The Regulatory Response to Abuse-Deterrent Drugs

Paul Howe, chief commercial officer at Protega Pharma, discusses how regulatory agencies are updating their policies based on the presence of abuse-deterrent medications.

USP Calls for Pharmacists to Volunteer to Advance Global Public Health Standards

Farah Towfic, PharmD, MBA, RPh, explains the importance of USP's expert volunteer recruitment, particularly among pharmacists, to help create public quality standards, promote health literacy, and support initiatives, with applications open until March 13, 2025, for the next strategic cycle beginning July 1, 2025.

RFK Jr. Says He’s Not Anti-Vaccine Ahead of Senate Hearings

Robert F. Kennedy Jr., President Donald Trump’s pick to head the Department of Health and Human Services, will tell senators this week that he is not “anti-vaccine or anti-industry.”

Pharmaceutical Regulatory Affairs Market Trends Analysis Report 2025-2030

The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical regulatory affairs market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 7.17% from 2025 to 2030.

Nicholas Saraceno on LinkedIn

For you audio fans - happy to report that my chat with Donald is the latest episode of the PC Podcast! Link to listen is below.
https://lnkd.in/e_JmyFW9

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs